Navigation Links
Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
Date:1/4/2012

THOUSAND OAKS, Calif., Jan. 4, 2012 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 30th Annual J.P. Morgan Global Healthcare Conference at 10:00 a.m. Pacific Time on Monday, Jan. 9, 2012, at the Westin St. Francis in San Francisco, Calif.  Robert A. Bradway, president and chief operating officer at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit www.amgen.com.  Follow us on www.twitter.com/amgen.

 

CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (media)
Arvind Sood, 805-447-1060 (investors)

(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)

 

 

 

 


'/>"/>
SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012
2. Amgen Announces 2012 First Quarter Dividend
3. Amgen Presents Final Results from the Largest Phase 3 Open-Label Study Assessing the Safety and Efficacy of Nplate® (Romiplostim)
4. Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy
5. Amgen’s Third Quarter 2011 Revenue and Adjusted Earnings Per Share (EPS) Each Increased 3 Percent to $3.9 Billion and $1.40
6. Amgen Appoints Anthony (Tony) Hooper Executive Vice President Global Commercial Operations
7. Amgen Appoints Robert A. Bradway to the Companys Board of Directors
8. Amgen Announces 2011 Fourth Quarter Dividend
9. Amgen to Present at the UBS Global Life Sciences Conference
10. Amgen Staff Volunteer Efforts Result in $5,000 For Each of Their Favorite Nonprofits
11. Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures(TM) Educational Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... SHANGHAI , CAMBRIDGE, Mass. and ... --  WuXi NextCODE , a WuXi AppTec group ... today announced that the company,s chief operating officer Hannes Smarason ... WuXi AppTec senior vice presidents John Long and ... and chief operating officer, respectively. "WuXi NextCODE ...
(Date:2/28/2017)... 28, 2017 WuXi AppTec, a leading ... and technology platform company, today announced that its ... Shanghai once again passed US FDA,s ... The inspectors from FDA thoroughly audited WuXi,s ... scientific data integrity, operation infrastructure, equipment, sample storage, ...
(Date:2/28/2017)... (PRWEB) , ... February 28, 2017 , ... ... trials, yet requires extensive coordination and expertise. Colpitts Clinical Trial Travel and ... 15 years of meeting this unique need within the biotechnology and pharmaceutical industries ...
(Date:2/28/2017)... PA (PRWEB) , ... February 28, 2017 , ... Over ... them children. In a new educational webinar on March 7, DrugDev will ... professionals working in this especially difficult area. , Webinar: Overcoming the Challenges of ...
Breaking Biology Technology:
(Date:2/8/2017)... 8, 2017 About Voice Recognition Biometrics Voice ... it against a stored voiceprint template. Acoustic features ... and tone are compared to distinguish between individual ... as most PCs already have a microphone and ... recognition biometrics are most likely to be deployed ...
(Date:2/7/2017)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce that the latest release ... flexible and award winning eClinical solution, is now available ... is a proven Software-as-a-Service (SaaS) clinical research technology platform ... also delivers an entire suite of eClinical tools to ...
(Date:2/3/2017)... 3, 2017 A new independent identity strategy ... LLP (IdSP) . Designed to fill a critical niche ... market, founding partners Mark Crego and ... just in identity expertise that span federal governments, the ... The Crego-Kephart combined expertise has a common theme born ...
Breaking Biology News(10 mins):